Abstract
BackgroundLong-term opioid use is associated with pharmacological tolerance, a risk of misuse and hyperalgesia in patients with chronic pain (CP). Tapering is challenging in this context, particularly with comorbid opioid-use disorder (OUD). The antihyperalgesic effect of ketamine, through N-methyl-D-aspartate (NMDA) antagonism, could be useful. We aimed to describe the changes in the dose of opioids consumed over 1 year after a 5-day hospitalisation with ketamine infusion for CP patients with OUD.MethodsWe performed a historical cohort study using a medical chart from 1 January 2014 to 31 December 2019. Patients were long-term opioid users with OUD and CP, followed by the Pain Center of the University Hospital of Toulouse, for which outpatient progressive tapering failed. Ketamine was administered at a low dose to initiate tapering during a 5-day hospitalisation.Results59 patients were included, with 64% of them female and a mean age of 48±10 years old. The most frequent CP aetiologies were back pain (53%) and fibromyalgia (17%). The baseline opioid daily dose was 207 mg (±128) morphine milligram equivalent (MME). It was lowered to 92±72 mg MME at discharge (p<0.001), 99±77 mg at 3 months (p<0.001) and 103±106 mg at 12 months. More than 50% tapering was achieved immediately for 40 patients (68%), with immediate cessation for seven patients (12%). 17 patients were lost to follow-up.ConclusionsA 5-day hospitalisation with a low-dose ketamine infusion appeared useful to facilitate opioid tapering in long-term opioid users with CP and OUD. Ketamine was well tolerated, and patients did not present significant withdrawal symptoms. Prospective and comparative studies are needed to confirm our findings.
Reference50 articles.
1. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality;Chenaf;Eur J Pain,2019
2. Opioid-induced hyperalgesia in community-dwelling adults with chronic pain;Hooten;Pain,2015
3. Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain
4. Efficacy of interventions to reduce long term opioid treatment for chronic non-cancer pain: systematic review and meta-analysis;Avery;BMJ,2022
5. French Health Authority . Appropriate use of opioid drugs: analgesia, prevention and management of use disorder and overdose. chronic non-cancer pain with opioid analgesic treatment [In French]. 2022. Available: https://www.has-sante.fr/jcms/p_3326096/fr/traitement-antalgique-opioide-de-la-douleur-chronique-non-cancereuse-fiche [Accessed 22 Sep 2023].
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献